Risk Management Shapes FDA Policies and Practices

In response to increasing concern about drug safety, FDA has implemented several administrative and policy changes, inclduing the new Office of Pharmacoepidemiology and Statistical Science and a renewed focus on risk assessment.

Related Content:

Quality SystemsRegulatory WatchPharmaceutical Technology-08-02-2002

The Future of Pharmaceutical Environmental Monitoring in Europe

Securing Europe’s Critical Entities from Cyber Attacks

Advancing Global Collaboration for Drug Testing, Regulation, and Manufacturing